Results 1 to 10 of about 1,916,251 (255)
Direct oral anticoagulants are becoming more commonplace for the treatment of nonvalvular atrial fibrillation and deep vein thrombosis. Unfortunately, effective reversal agents are not widely available limiting options for neurosurgical intervention ...
Joseph H. McMordie, MD +3 more
doaj +2 more sources
Intracranial hemorrhage in the era of the “direct” oral anticoagulants [PDF]
Intracranial hemorrhage (ICH) is the most severe complication in patients treated with oral anticoagulants (OACs). Duration of anticoagulant therapy and poor anticoagulation control are important factors for hemorrhagic risk.
Ileana Raluca Nistor, Leonida Gherasim
doaj +3 more sources
Using the CHOPS score to evaluate the severe cerebral venous sinus thrombosis progression risk after anticoagulation [PDF]
ObjectiveThis aimed to evaluate the risk of severe cerebral venous sinus thrombosis (SCVST) progression after anticoagulation using clinical and radiological data.MethodsClinical and radiological data from 199 SCVST patients were collected and analyzed ...
Ya-Qi Liu +5 more
doaj +2 more sources
Improved Cardiovascular Tolerance to Hemorrhage after Oral Resveratrol Pretreatment in Dogs [PDF]
Resveratrol has been shown to preserve organ function and improve survival in hemorrhagic shock rat models. This study investigated whether seven days of oral resveratrol could improve hemodynamic response to hemorrhage and confer benefits on risk of ...
Jennifer Davis +5 more
doaj +2 more sources
Management of intractable oronasal bleeding using Sengstaken-Blakemore tubes in patients with facial trauma: a case series and technical notes [PDF]
Objective Intractable massive oronasal bleeding can become a life-threatening condition. The success rate of conventional bleeding control methods other than transarterial embolization (TAE) is not expected to be high.
Gi Woon Kim +5 more
doaj +1 more source
ObjectiveWe reported the long-term outcomes of transcatheter chemoembolization (TACE) for patients with late-stage or recurrent oral carcinoma.MethodsThis retrospective study enrolled 18 patients with late-stage or recurrent oral carcinoma between ...
Yonghua Bi +7 more
doaj +1 more source
Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou +6 more
doaj +1 more source
Background: The meta-analysis of randomized controlled trials has illustrated that the efficacy of low-dose non-vitamin K antagonist oral anticoagulants is inferior compared with standard-dose non-vitamin K antagonist oral anticoagulants, though they are
Zei Li +6 more
doaj +1 more source
Management of Oral Anti-Thrombotic Agents Associated Intracerebral Hemorrhage [PDF]
Oral anti-thrombotic agents including anti-coagulants or anti-platelet agents are widely used to prevent cerebral infarction in patients with certain risk factors for ischemic stroke. Oral anti-coagulants, particularly warfarin, have long been used after
Yoonkyung Chang +2 more
doaj +1 more source
Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation [PDF]
Patients with atrial fibrillation who had a previous transient ischemic attack or ischemic stroke had a significantly high risk of stroke recurrence and the introduction of oral anticoagulants should be mandatory.
Jovanović Dejana R.
doaj +1 more source

